Anal cancer, like carcinoma of the cervix, is strongly associated with human papilloma virus (HPV) infection. In the past few decades, treatment has swung away dramatically from primary surgery to definitive chemoradiotherapy, with the evident physical and psychosocial benefits of organ preservation. Tumours of lower stage T1 or T2, N0, have an excellent outcome with the chemoradiotherapy approach. Unfortunately, many patients present with T3, T4 or N ≥ 1 disease and they have a significant risk of both locoregional and subsequent distant failure. Half of patients still die within 5 years of treatment. Therefore, efforts are ongoing to improve outcomes via better local and systemic therapy
Anal squamous cell carcinoma is an uncommon Human Papilloma Virus (HPV)‐related malignancy, the inci...
Management of patients with squamous cell carcinoma of the anus (SCCA) has remained virtually unchan...
AbstractBackgroundAnal canal carcinoma is a rare neoplasm, representing 2% of the digestive tumors, ...
Anal cancer, like carcinoma of the cervix, is strongly associated with human papilloma virus (HPV) i...
Anal cancer is a relatively rare, mostly HPV-related cancer. The curative treatment consists of conc...
Diagnosis and Therapy of Anal Carcinoma Summary. The squamous cell carcinoma of the anorectum is rar...
Cancer of the anal region represents 3-3.5% of all anorectal tumours. The peak incidence is between ...
The incidence of anal cancer is increasing. In the UK, the incidence is estimated at approximately 1...
Squamous cell carcinoma of the anus is an orphan disease, and after more than three decades of no su...
During the past 30 years, there has been remarkable progress in our understanding of the pathogenesi...
Background Squamous cell carcinoma of the anus (SCCA) is a rare malignancy with rising incidence, a...
AbstractSquamous cell carcinoma of the anus (SCCA) is a rare cancer but its incidence is increasing ...
Anal cancer is a rare condition, although its incidence has been increasing over the past several de...
The definitive version is available at www.blackwell-synergy.comAim: Concurrent chemoradiotherapy is...
Treatment of squamous cell carcinoma of the anus has evolved over the last 5 decades from radical su...
Anal squamous cell carcinoma is an uncommon Human Papilloma Virus (HPV)‐related malignancy, the inci...
Management of patients with squamous cell carcinoma of the anus (SCCA) has remained virtually unchan...
AbstractBackgroundAnal canal carcinoma is a rare neoplasm, representing 2% of the digestive tumors, ...
Anal cancer, like carcinoma of the cervix, is strongly associated with human papilloma virus (HPV) i...
Anal cancer is a relatively rare, mostly HPV-related cancer. The curative treatment consists of conc...
Diagnosis and Therapy of Anal Carcinoma Summary. The squamous cell carcinoma of the anorectum is rar...
Cancer of the anal region represents 3-3.5% of all anorectal tumours. The peak incidence is between ...
The incidence of anal cancer is increasing. In the UK, the incidence is estimated at approximately 1...
Squamous cell carcinoma of the anus is an orphan disease, and after more than three decades of no su...
During the past 30 years, there has been remarkable progress in our understanding of the pathogenesi...
Background Squamous cell carcinoma of the anus (SCCA) is a rare malignancy with rising incidence, a...
AbstractSquamous cell carcinoma of the anus (SCCA) is a rare cancer but its incidence is increasing ...
Anal cancer is a rare condition, although its incidence has been increasing over the past several de...
The definitive version is available at www.blackwell-synergy.comAim: Concurrent chemoradiotherapy is...
Treatment of squamous cell carcinoma of the anus has evolved over the last 5 decades from radical su...
Anal squamous cell carcinoma is an uncommon Human Papilloma Virus (HPV)‐related malignancy, the inci...
Management of patients with squamous cell carcinoma of the anus (SCCA) has remained virtually unchan...
AbstractBackgroundAnal canal carcinoma is a rare neoplasm, representing 2% of the digestive tumors, ...